Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB09247ApprovedWithdrawnSmall molecule
Iproclozide is an irreversible and selective hydrazine class based monoamine oxidase inhibitor (MAOI). Although it was employed as an antidepressant for a time, the fact that the agent is capable... Although it was employed as an antidepressant for a time, the fact that the agent is capable of causing fulminant hepatitis and that its use has been documented as the cause for at least three...
- Primary indication
- For the treatment of depression.Curator reviewed
- Formula / weight
- C11H15ClN2O2 · 242.7 g/mol (avg)
- Code names
- PC-603
Resolves to
Clinical / RWD
Structure
InChIKey
GGECDTUJZOXAAR-UHFFFAOYSA-NSMILESCC(C)NNC(=O)COC1=CC=C(Cl)C=C1What you can answer from here — as of March 06, 2025
Which companies are running trials of Iproclozide, in which indications and phases, and which of those programs are still active?